Multifocal motor neuropathy
MMN · Neurology · 2 drugs · 1 indications
Rare immune-mediated neuropathy affecting motor nerves.
Competitive Landscape (2 drugs)
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|
| Empasiprubart | ARGX | C2 Complement Inhibitor | Antibody | IV | PHASE3 |
| Claseprubart | — | Selective classical complement C1s inhibitor | Monoclonal antibody | SC | PHASE3 |
Indications (1)
Multifocal Motor Neuropathy
Upcoming Catalysts
Claseprubart - gMG - Ph3 - Trial InitiationCLINICAL
DNTH2026
Claseprubart - CIDP - Ph3 - Interim Responder Analysis (CAPTIVATE Part A, n=40)CLINICAL
DNTHQ2 2026
Claseprubart - MMN - Ph2 - Topline Data (MoMeNtum)CLINICAL
DNTHH2 2026
Empasiprubart - MMN - Ph3 - ToplineCLINICAL
ARGXQ4 2026
Empasiprubart - CIDP - Ph3 - ToplineCLINICAL
ARGXH2 2027
Data from Supabase · Updated 2026-03-24